Recommended Childhood and Adolescent Immunization Schedule—United States, 2017
2017; American Academy of Pediatrics; Volume: 139; Issue: 3 Linguagem: Inglês
10.1542/peds.2016-4007
ISSN1098-4275
Tópico(s)Child and Adolescent Health
ResumoThe 2017 recommended childhood and adolescent immunization schedules have been approved by the American Academy of Pediatrics, the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention, the American Academy of Family Physicians, and the American College of Obstetricians and Gynecologists. The schedules are revised annually to reflect current recommendations for the use of vaccines licensed by the US Food and Drug Administration.The 2017 format of Fig 1 is similar to the 2016 schedule consisting of a single table for persons from birth through 18 years of age. The yellow bars indicate the recommended age range for all children and contain a notation indicating the recommended dose number by age. The green bars indicate the recommended catch-up age. The purple bars designate the range for immunization for certain groups at high risk. The blue bars indicate the range of recommended doses for persons in non–high-risk groups who may receive a vaccine, subject to individual decision-making. The white boxes show the ages at which a vaccine is not recommended routinely. The columns that begin with a gray-shaded box indicate vaccine recommendations for school entry and at adolescent visits. The following specific changes have been made to the 2017 schedule:Figure 2 is the catch-up immunization schedule offering recommendations for children and adolescents who start late or are >1 month behind. As in previous years, the catch-up schedule is divided into sections for children ages 4 months through 6 years and children and adolescents ages 7 through 18 years. No changes have been made to the 2017 catch-up immunization figure. Tables (job aids) are available to assist in the clarification of the recommended use of Haemophilus influenzae type b, pneumococcal, and pertussis-containing vaccines as a function of age; the number of doses previously administered; and the time interval since the last dose.Figure 3 is a new table that addresses which vaccines may be indicated for persons aged 0 through 18 years who have a specific medical indication. This figure indicates vaccines that may be administered during pregnancy or to children and adolescents with an immunocompromising condition; kidney, heart, or liver disease; a cochlear implant; a cerebrospinal fluid leak; asplenia; a complement deficiency; or diabetes. Figure 3 in the childhood/adolescent schedule is similar to Fig 2 in the adult immunization schedule.Footnotes contain recommendations for routine vaccination, for catch-up vaccination, as well as for vaccination of children and adolescents with high-risk conditions or in special circumstances. Recommendations in the figures should be read with the corresponding footnotes. Changes have been made to the following footnotes:In addition to publication of the schedules in this issue of Pediatrics, the 2017 version of Figs 1 through 3, the catch-up schedule, the footnotes, and job aids are available at the AAP Web site (https://redbook.solutions.aap.org/selfserve/ssPage.aspx?SelfServeContentId=Immunization_Schedules) and the Centers for Disease Control and Prevention Web site (https://www.cdc.gov/vaccines/schedules/). A parent-friendly vaccine schedule for children and adolescents is available at http://www.cdc.gov/vaccines/schedules/index.html. An adult immunization schedule is published in February of each year and is available at www.cdc.gov/vaccines.Clinically significant adverse events that follow immunization should be reported to the Vaccine Adverse Event Reporting System (VAERS). Guidance about how to obtain and complete a VAERS form can be obtained at www.vaers.hhs.gov or by calling 800-822-7967. Additional information can be found in the Red Book and at Red Book Online (http://aapredbook.aappublications.org/). Statements from the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention that contain detailed recommendations for individual vaccines, including recommendations for children with high-risk conditions, are available at www.cdc.gov/vaccines/pubs/ACIP-list.htm. Information on new vaccine releases, vaccine supplies, and interim recommendations resulting from vaccine shortages and statements on specific vaccines can be found at www.aapredbook.org/news/vaccstatus.shtml and www.cdc.gov/vaccines/pubs/ACIP-list.htm. Carrie L. Byington, MD, FAAP, ChairpersonYvonne A. Maldonado, MD, FAAP, Vice ChairpersonElizabeth D. Barnett, MD, FAAPJames D. Campbell, MD, FAAPH. Dele Davies, MD, MS, MHCM, FAAPRuth Lynfield, MD, FAAPFlor M. Munoz, MD, FAAPDawn Nolt, MD, MPH, FAAPAnn Christine Nyquist, MD, MSPH, FAAPSean O'Leary, MD, MPH, FAAPMobeen H. Rathore, MD, FAAPMark H. Sawyer, MD, FAAPWilliam J. Steinbach, MD, FAAPTina Q. Tan, MD, FAAPTheoklis E. Zaoutis, MD, MSCE, FAAPDavid W. Kimberlin, MD, FAAP – Red Book EditorMichael T. Brady, MD, FAAP – Red Book Associate EditorMary Anne Jackson, MD, FAAP – Red Book Associate EditorSarah S. Long, MD, FAAP – Red Book Associate EditorHenry H. Bernstein, DO, MHCM, FAAP – Red Book Online Associate EditorH. Cody Meissner, MD, FAAP – Visual Red Book Associate EditorDouglas Campos-Outcalt, MD, MPA – American Academy of Family PhysiciansAmanda C. Cohn, MD, FAAP – Centers for Disease Control and PreventionKaren M. Farizo, MD – US Food and Drug AdministrationMarc Fischer, MD, FAAP – Centers for Disease Control and PreventionBruce G. Gellin, MD, MPH – National Vaccine Program OfficeRichard L. Gorman, MD, FAAP – National Institutes of HealthNatasha Halasa, MD, MPH, FAAP – Pediatric Infectious Diseases SocietyJoan L. Robinson, MD – Canadian Paediatric SocietyJamie Deseda-Tous, MD – Sociedad Latinoamericana de Infectologia Pediatrica (SLIPE)Geoffrey R. Simon, MD, FAAP – Committee on Practice Ambulatory MedicineJeffrey R. Starke, MD, FAAP – American Thoracic SocietyJennifer M. Frantz, MPH
Referência(s)